{"DataElement":{"publicId":"6572601","version":"1","preferredName":"Differentiated Thyroid Cancer AJCC Edition 8 Pathologic Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for differentiated thyroid carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"DTC_AJC8_PTH_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6572587","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma Pathologic N Category","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"3461579v1.0:2428379v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"3461579","version":"1","preferredName":"Differentiated Thyroid Gland Carcinoma","preferredDefinition":"An adenocarcinoma arising from the thyroid gland showing extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary, or follicular carcinoma. (NCI05)","longName":"C7153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Differentiated Thyroid Gland Carcinoma","conceptCode":"C7153","definition":"An adenocarcinoma that arises from the thyroid gland and shows extensive evidence of follicular cell differentiation.  According to the nuclear features of the malignant follicular cells, it is classified either as papillary or follicular carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C02DD092-1787-CCAB-E040-BB89AD430207","latestVersionIndicator":"Yes","beginDate":"2012-05-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-16","modifiedBy":"ONEDATA","dateModified":"2012-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428379","version":"1","preferredName":"Pathologic N Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-084E-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7BD2C0F1-D136-3F51-E053-F662850A1E32","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6572540","version":"1","preferredName":"Differentiated and Anaplastic Thyroid Carcinoma American Joint Committee on Cancer Edition 8 Pathologic N Category","preferredDefinition":"A pathologic finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6572540v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N1b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1b TNM Finding v8","ValueMeaning":{"publicId":"6572542","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1b TNM Finding v8","longName":"6572542","preferredDefinition":"Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1b TNM Finding v8","conceptCode":"C140935","definition":"Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC0A2D3-1008-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-1021-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1a TNM Finding v8","ValueMeaning":{"publicId":"6572544","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1a TNM Finding v8","longName":"6572544","preferredDefinition":"Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1a TNM Finding v8","conceptCode":"C140932","definition":"Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC0A2D3-102E-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-1047-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N1","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1 TNM Finding v8","ValueMeaning":{"publicId":"6572546","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1 TNM Finding v8","longName":"6572546","preferredDefinition":"Metastasis to regional nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN1 TNM Finding v8","conceptCode":"C140929","definition":"Metastasis to regional nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC0A2D3-1054-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-106D-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0a","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","ValueMeaning":{"publicId":"6572516","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","longName":"6572516","preferredDefinition":"One or more cytologically or histologically confirmed benign lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0a TNM Finding v8","conceptCode":"C140928","definition":"One or more cytologically or histologically confirmed benign lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA2A-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-1077-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0 TNM Finding v8","ValueMeaning":{"publicId":"6572548","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0 TNM Finding v8","longName":"6572548","preferredDefinition":"No evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pN0 TNM Finding v8","conceptCode":"C140927","definition":"No evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC0A2D3-1084-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-109D-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"NX","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pNX TNM Finding v8","ValueMeaning":{"publicId":"6572550","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pNX TNM Finding v8","longName":"6572550","preferredDefinition":"Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma pNX TNM Finding v8","conceptCode":"C140926","definition":"Regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BC0A2D3-10AA-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-10C3-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"},{"value":"N0b","valueDescription":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","ValueMeaning":{"publicId":"6572514","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","longName":"6572514","preferredDefinition":"No radiologic or clinical evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma cN0b TNM Finding v8","conceptCode":"C140905","definition":"No radiologic or clinical evidence of locoregional lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BD1AEDC-BA04-42BF-E053-F662850A427D","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BC0A2D3-10CD-591B-E053-F662850A84DF","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"ONEDATA","dateModified":"2018-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6868597","version":"1","preferredName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma Pathologic TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140909:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary, Follicular, Hurthle Cell, Poorly Differentiated, and Anaplastic Thyroid Carcinoma Pathologic TNM Finding v8","conceptCode":"C140909","definition":"A pathologic finding about one or more characteristics of papillary, follicular, Hurthle cell, poorly differentiated, and anaplastic thyroid carcinoma, following the rules of the TNM AJCC v8 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9146092B-EB86-4997-E053-F662850A6C72","latestVersionIndicator":"Yes","beginDate":"2019-08-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-29","modifiedBy":"ONEDATA","dateModified":"2019-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BC0A2D3-0FEC-591B-E053-F662850A84DF","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000440","version":"1","longName":"Thyroid","context":"NCI Standards"}]},{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779571","version":"1","longName":"THCA Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic N category","type":"Preferred Question Text","description":"Pathologic N category","url":null,"context":"NCI Standards"},{"name":"CPTAC-BSLN-1","type":"Alternate Question Text","description":"Pathologic Regional Lymph Node Status (pN)","url":null,"context":"OCCPR"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BD44DBD-AB54-2DC8-E053-F662850A7398","latestVersionIndicator":"Yes","beginDate":"2018-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-29","modifiedBy":"TAYLORT","dateModified":"2020-04-03","changeDescription":"4/3/20 tmt released. 4/2/20 jk added CPTAC CSI, AQT.  11/29/18 tmt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}